These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 2982051

  • 1. Serum concentration and effects of a single dose of enalapril maleate in patients with essential hypertension.
    Shionoiri H, Gotoh E, Miyazaki N, Yasuda G, Takagi N, Uneda S, Kaneko Y.
    Jpn Circ J; 1985 Jan; 49(1):46-51. PubMed ID: 2982051
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of enalapril maleate (MK-421) on blood pressure, renin-angiotensin system and kallikrein-kinin system in patients with essential hypertension].
    Shionoiri H, Akema N, Tanaka K, Miyazaki N, Gotoh E, Kaneko Y.
    Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):759-65. PubMed ID: 6096606
    [No Abstract] [Full Text] [Related]

  • 5. Immunoreactive bradykinin and [des-Arg9]-bradykinin in low-renin essential hypertension--before and after treatment with enalapril (MK 421).
    Odya CE, Wilgis FP, Walker JF, Oparil S.
    J Lab Clin Med; 1983 Nov; 102(5):714-21. PubMed ID: 6313833
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Correlation between angiotensin converting enzyme inhibition and the acute hypotensive response to MK 421 in essential hypertension.
    Jackson B, McGrath BP, Johnston CI.
    Clin Exp Pharmacol Physiol Suppl; 1982 Nov; 7():99-104. PubMed ID: 6291832
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of the oral angiotensin-converting enzyme inhibitor MK-421 in human hypertension.
    Gavras H, Biollaz J, Waeber B, Brunner HR, Gavras I, Sackel H, Charocopos F, Davies RO.
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():281s-283s. PubMed ID: 6274572
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G, Cottone S, D'Ignoto G, Grasso L, Carone MB, Carapelle E, Contorno A.
    Clin Ther; 1987 Dec; 9(4):390-9. PubMed ID: 3038326
    [Abstract] [Full Text] [Related]

  • 16. Effects of enalapril, a new converting enzyme inhibitor, in hypertension.
    Ferguson RK, Vlasses PH, Swanson BN, Mojaverian P, Hichens M, Irvin JD, Huber PB.
    Clin Pharmacol Ther; 1982 Jul; 32(1):48-53. PubMed ID: 6282527
    [Abstract] [Full Text] [Related]

  • 17. Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension.
    Johnston CI, Jackson BJ, Larmour I, Cubella R, Casley D.
    Br J Clin Pharmacol; 1984 Jul; 18 Suppl 2(Suppl 2):233S-239S, 241S. PubMed ID: 6099738
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.